The rationale for combining them is mechanistic complementarity (different signaling pathways, all three implicated in tissue repair and dermal remodeling) and clinical anecdote in the peptide-therapy community not formal head-to-head, combination-vs-monotherapy, or concentration-response data on the blend itself
After nearly a decade of working in parallel at campuses separated by just four miles, Friederike Jayes, DVM, PhD, Assistant Professor in Obstetrics and Gynecology at the Duke University School of Medicine, and Darlene Taylor, PhD, Professor of Chemistry and Biochemistry at NCCU, are now combining their research to advance a fundamentally new approach for treating uterine fibroids
An anovulatory phenotype with disrupted cycle regularity as the primary concern points toward kisspeptin-adjacent approaches
[DOI] [PMC free article] [PubMed] [Google Scholar] 374.Onishi A, Sugiyama D, Kumagai S & Morinobu A Cancer incidence in systemic sclerosis: meta-analysis of population-based cohort studies
cancer, sinusitis